Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Clinical development of mAbs to block the PD1 pathway as an immunotherapy for cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Clinical development of mAbs to block the PD1 pathway as an immunotherapy for cancer.
Clinical development of mAbs to block the PD1 pathway as an immunotherapy for cancer. Curr Opin Investig Drugs. 2010 Dec; 11(12):1354-9.
View in:
PubMed
subject areas
Animals
Antibodies, Monoclonal
Antigens, CD
Apoptosis Regulatory Proteins
B7-H1 Antigen
Clinical Trials as Topic
Disease Models, Animal
Female
Humans
Immunotherapy
Male
Mice
Neoplasms
Programmed Cell Death 1 Receptor
Signal Transduction
T-Lymphocytes
Tumor Microenvironment
authors with profiles
Thomas F. Gajewski
Justin P. Kline